Published in BMC Bioinformatics on January 10, 2008
Using cross-validation to evaluate predictive accuracy of survival risk classifiers based on high-dimensional data. Brief Bioinform (2011) 1.69
CMA: a comprehensive Bioconductor package for supervised classification with high dimensional data. BMC Bioinformatics (2008) 1.68
Incorporating pathway information into boosting estimation of high-dimensional risk prediction models. BMC Bioinformatics (2009) 1.52
Testing the additional predictive value of high-dimensional molecular data. BMC Bioinformatics (2010) 1.27
Flexible boosting of accelerated failure time models. BMC Bioinformatics (2008) 1.26
Survival prediction from clinico-genomic models--a comparative study. BMC Bioinformatics (2009) 1.18
Transforming RNA-Seq data to improve the performance of prognostic gene signatures. PLoS One (2014) 1.10
Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer. PLoS One (2011) 1.02
Survival models with preclustered gene groups as covariates. BMC Bioinformatics (2011) 0.98
Graph based fusion of miRNA and mRNA expression data improves clinical outcome prediction in prostate cancer. BMC Bioinformatics (2011) 0.96
Random survival forests for competing risks. Biostatistics (2014) 0.93
Comparative optimism in models involving both classical clinical and gene expression information. BMC Bioinformatics (2008) 0.92
A comparative study on gene-set analysis methods for assessing differential expression associated with the survival phenotype. BMC Bioinformatics (2011) 0.89
Semiparametric prognosis models in genomic studies. Brief Bioinform (2010) 0.88
Prognostic value of single nucleotide polymorphisms of candidate genes associated with inflammation in early stage breast cancer. Breast Cancer Res Treat (2013) 0.86
Novel image markers for non-small cell lung cancer classification and survival prediction. BMC Bioinformatics (2014) 0.86
Cross-study validation for the assessment of prediction algorithms. Bioinformatics (2014) 0.85
Joint impact of clinical and behavioral variables on the risk of unplanned readmission and death after a heart failure hospitalization. PLoS One (2015) 0.81
Big data in medical science--a biostatistical view. Dtsch Arztebl Int (2015) 0.80
Gene selection using iterative feature elimination random forests for survival outcomes. IEEE/ACM Trans Comput Biol Bioinform (2012) 0.80
Competing risks data analysis with high-dimensional covariates: an application in bladder cancer. Genomics Proteomics Bioinformatics (2015) 0.79
Added predictive value of omics data: specific issues related to validation illustrated by two case studies. BMC Med Res Methodol (2014) 0.78
Combining techniques for screening and evaluating interaction terms on high-dimensional time-to-event data. BMC Bioinformatics (2014) 0.78
Genomic copy number imbalances associated with bone and non-bone metastasis of early-stage breast cancer. Breast Cancer Res Treat (2013) 0.77
A weighting approach for judging the effect of patient strata on high-dimensional risk prediction signatures. BMC Bioinformatics (2015) 0.77
Random rotation survival forest for high dimensional censored data. Springerplus (2016) 0.75
Predicting survival time for metastatic castration resistant prostate cancer: An iterative imputation approach. F1000Res (2016) 0.75
Identifying Prognostic SNPs in Clinical Cohorts: Complementing Univariate Analyses by Resampling and Multivariable Modeling. PLoS One (2016) 0.75
Integrating multiple molecular sources into a clinical risk prediction signature by extracting complementary information. BMC Bioinformatics (2016) 0.75
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med (2002) 24.07
The lasso method for variable selection in the Cox model. Stat Med (1997) 18.10
A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med (1993) 17.71
Consistent estimation of the expected Brier score in general survival models with right-censored event times. Biom J (2006) 2.55
Predicting patient survival from microarray data by accelerated failure time modeling using partial least squares and LASSO. Biometrics (2007) 2.07
Supervised group Lasso with applications to microarray data analysis. BMC Bioinformatics (2007) 1.99
Assessment of survival prediction models based on microarray data. Bioinformatics (2007) 1.79
Efron-type measures of prediction error for survival analysis. Biometrics (2007) 1.58
Microarray gene expression data with linked survival phenotypes: diffuse large-B-cell lymphoma revisited. Biostatistics (2005) 1.56
Penalized likelihood in Cox regression. Stat Med (1995) 1.42
Additive risk survival model with microarray data. BMC Bioinformatics (2007) 1.40
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet (2009) 6.92
Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis (2010) 3.23
Undue reliance on I(2) in assessing heterogeneity may mislead. BMC Med Res Methodol (2008) 3.06
Twenty years experience with an ileal orthotopic low pressure bladder substitute--lessons to be learned. J Urol (2006) 2.82
Nerve sparing open radical retropubic prostatectomy--does it have an impact on urinary continence? J Urol (2006) 2.65
Consistent estimation of the expected Brier score in general survival models with right-censored event times. Biom J (2006) 2.55
The performance of risk prediction models. Biom J (2008) 2.00
Risk factors for the development of nosocomial pneumonia and mortality on intensive care units: application of competing risks models. Crit Care (2008) 1.98
Proportional subdistribution hazards modeling offers a summary analysis, even if misspecified. Stat Med (2010) 1.94
A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics (2008) 1.92
How many infections are caused by patient-to-patient transmission in intensive care units? Crit Care Med (2005) 1.87
Transvenous treatment of carotid cavernous and dural arteriovenous fistulae: results for 31 patients and review of the literature. Neurosurgery (2003) 1.76
Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients. Clin Cancer Res (2006) 1.75
Prospective population-based study of viral lower respiratory tract infections in children under 3 years of age (the PRI.DE study). Eur J Pediatr (2004) 1.72
Modeling the effect of time-dependent exposure on intensive care unit mortality. Intensive Care Med (2009) 1.66
Simulating competing risks data in survival analysis. Stat Med (2009) 1.62
On pseudo-values for regression analysis in competing risks models. Lifetime Data Anal (2008) 1.60
Circadian incidence of non-inflammatory retinal artery occlusions. Graefes Arch Clin Exp Ophthalmol (2008) 1.59
Oncologic, functional, and complications outcomes of robot-assisted radical cystectomy with totally intracorporeal neobladder diversion. Eur Urol (2013) 1.58
Efron-type measures of prediction error for survival analysis. Biometrics (2007) 1.58
Valproate-induced encephalopathy: assessment with MR imaging and 1H MR spectroscopy. Epilepsia (2002) 1.55
Quality control after cochlear implant surgery by means of rotational tomography. Otol Neurotol (2005) 1.54
Incorporating pathway information into boosting estimation of high-dimensional risk prediction models. BMC Bioinformatics (2009) 1.52
Use of the alkaline in vivo Comet assay for mechanistic genotoxicity investigations. Mutagenesis (2004) 1.44
Solitary spinal artery aneurysms as a rare source of spinal subarachnoid hemorrhage: potential etiology and treatment strategy. AJNR Am J Neuroradiol (2005) 1.43
The relationship between quality of research and citation frequency. BMC Med Res Methodol (2006) 1.40
Intrathecal gadolinium-enhanced MR myelography showing multiple dural leakages in a patient with Marfan syndrome. AJR Am J Roentgenol (2005) 1.40
[Neuropsychiatric involvement in systemic lupus erythematosus. Part 2: diagnostic and therapy]. Med Klin (Munich) (2003) 1.40
A competing risks analysis of bloodstream infection after stem-cell transplantation using subdistribution hazards and cause-specific hazards. Stat Med (2007) 1.37
The congenital unilateral retinocephalic vascular malformation syndrome (bonnet-dechaume-blanc syndrome or wyburn-mason syndrome): review of the literature. Surv Ophthalmol (2008) 1.32
Understanding competing risks: a simulation point of view. BMC Med Res Methodol (2011) 1.31
Prognosis of central retinal artery occlusion: local intraarterial fibrinolysis versus conservative treatment. AJNR Am J Neuroradiol (2002) 1.30
Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. J Invest Dermatol (2013) 1.28
Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data. Cochrane Database Syst Rev (2009) 1.26
Misspecified regression model for the subdistribution hazard of a competing risk. Stat Med (2007) 1.26
Palliative care for older people - exploring the views of doctors and nurses from different fields in Germany. BMC Palliat Care (2009) 1.24
Inflation of type I error rate in two statistical tests for the detection of publication bias in meta-analyses with binary outcomes. Stat Med (2002) 1.23
An easy mathematical proof showed that time-dependent bias inevitably leads to biased effect estimation. J Clin Epidemiol (2008) 1.22
Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus: a multistate analysis with follow-up beyond hospital discharge. J Antimicrob Chemother (2010) 1.22
Reporting of eligibility criteria of randomised trials: cohort study comparing trial protocols with subsequent articles. BMJ (2011) 1.19
Estimators and confidence intervals for the marginal odds ratio using logistic regression and propensity score stratification. Stat Med (2010) 1.18
The impact of time-dependent bias in proportional hazards modelling. Stat Med (2008) 1.18
In vivo wall shear stress distribution in the carotid artery: effect of bifurcation geometry, internal carotid artery stenosis, and recanalization therapy. Circ Cardiovasc Imaging (2010) 1.17
Nosocomial infection, length of stay, and time-dependent bias. Infect Control Hosp Epidemiol (2009) 1.16
Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany. Eur J Pediatr (2005) 1.15
Time-dependent covariates in the proportional subdistribution hazards model for competing risks. Biostatistics (2008) 1.15
Boosting for high-dimensional time-to-event data with competing risks. Bioinformatics (2009) 1.15
Time-dependent study entries and exposures in cohort studies can easily be sources of different and avoidable types of bias. J Clin Epidemiol (2012) 1.13
Treatment-effect estimates adjusted for small-study effects via a limit meta-analysis. Biostatistics (2010) 1.13
Representativeness of the surveillance data in the intensive care unit component of the German nosocomial infections surveillance system. Infect Control Hosp Epidemiol (2010) 1.12
Carotid cavernous fistula: embolization via a bilateral superior ophthalmic vein approach. AJNR Am J Neuroradiol (2002) 1.12
Confidence intervals for the effect of a prognostic factor after selection of an 'optimal' cutpoint. Stat Med (2004) 1.10
Estimating a time-dependent concordance index for survival prediction models with covariate dependent censoring. Stat Med (2012) 1.09
Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer: a randomized trial (GABG-IV D-93)--the German Adjuvant Breast Cancer Group. J Clin Oncol (2005) 1.09
Adapting prediction error estimates for biased complexity selection in high-dimensional bootstrap samples. Stat Appl Genet Mol Biol (2008) 1.09
Evidence from nonrandomized studies: a case study on the estimation of causal effects. Am J Epidemiol (2008) 1.07
Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity? Neurourol Urodyn (2005) 1.07
Survival in surgically treated, nodal positive prostate cancer patients is predicted by histopathological characteristics of the primary tumor and its lymph node metastases. Prostate (2009) 1.05
The brain tumor board: lessons to be learned from an interdisciplinary conference. Onkologie (2005) 1.05
C-arm cone beam computed tomography needle path overlay for image-guided procedures of the spine and pelvis. Neuroradiology (2011) 1.04
Comparison of three-dimensional rotational angiography with digital subtraction angiography in the assessment of ruptured cerebral aneurysms. AJNR Am J Neuroradiol (2002) 1.03
Gene profiling of clinical routine biopsies and prediction of survival in non-small cell lung cancer. Am J Respir Crit Care Med (2009) 1.02
Analysis of independent microarray datasets of renal biopsies identifies a robust transcript signature of acute allograft rejection. Transpl Int (2008) 1.01
Case report: brain and liver abscesses caused by oral infection with Streptococcus intermedius. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2006) 1.00
Simpson's paradox visualized: the example of the rosiglitazone meta-analysis. BMC Med Res Methodol (2008) 1.00
C-reactive protein, carotid atherosclerosis, and cerebral small-vessel disease: results of the Austrian Stroke Prevention Study. Stroke (2006) 0.99
Sample sizes for clinical trials with time-to-event endpoints and competing risks. Contemp Clin Trials (2005) 0.98
Cluster-localized sparse logistic regression for SNP data. Stat Appl Genet Mol Biol (2012) 0.98
Summary ROC curve based on a weighted Youden index for selecting an optimal cutpoint in meta-analysis of diagnostic accuracy. Stat Med (2010) 0.98
Application of multistate models in hospital epidemiology: advances and challenges. Biom J (2011) 0.96
Comment on 'Network-constrained regularization and variable selection for analysis of genomic data'. Bioinformatics (2008) 0.94
Nondestructive three-dimensional analysis of electrode to modiolus proximity. Otol Neurotol (2002) 0.92
Robot-assisted radical cystectomy: description of an evolved approach to radical cystectomy. Eur Urol (2013) 0.92
Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe. Orphanet J Rare Dis (2011) 0.91
Mechanical thrombolysis in acute ischemic stroke with endovascular photoacoustic recanalization. Stroke (2004) 0.91
Incidence densities in a competing events analysis. Am J Epidemiol (2010) 0.91
A test for publication bias in meta-analysis with sparse binary data. Stat Med (2007) 0.91
Statistically significant papers in psychiatry were cited more often than others. J Clin Epidemiol (2007) 0.90
Dynamic magnetic resonance imaging of swallowing and laryngeal motion using parallel imaging at 3 T. Magn Reson Imaging (2008) 0.90
Competing risks and multistate models. Clin Cancer Res (2012) 0.89
Aggressive versus conservative initiation of antibiotics. Lancet Infect Dis (2013) 0.89
Vocal tract in female registers--a dynamic real-time MRI study. J Voice (2009) 0.88
A note on variance estimation of the Aalen-Johansen estimator of the cumulative incidence function in competing risks, with a view towards left-truncated data. Biom J (2010) 0.88
Endovascular treatment of complex aneurysms at the vertebrobasilar junction with flow-diverting stents: initial experience. Neurosurgery (2013) 0.87
Multi-state model for studying an intermediate event using time-dependent covariates: application to breast cancer. BMC Med Res Methodol (2013) 0.87
Carotid intima-media thickness and distensibility measured by MRI at 3 T versus high-resolution ultrasound. Eur Radiol (2009) 0.87
Comments on 'The performance of different propensity score methods for estimating marginal odds ratios'. Stat Med (2008) 0.87
An overview of techniques for linking high-dimensional molecular data to time-to-event endpoints by risk prediction models. Biom J (2011) 0.87
Quantifying the predictive accuracy of time-to-event models in the presence of competing risks. Biom J (2011) 0.87
Parallelized prediction error estimation for evaluation of high-dimensional models. Bioinformatics (2009) 0.86
Blood hemoglobin level and treatment outcome of early breast cancer. Strahlenther Onkol (2004) 0.86
A randomised trial of goserelin versus control after adjuvant, risk-adapted chemotherapy in premenopausal patients with primary breast cancer - GABG-IV B-93. Eur J Cancer (2007) 0.86
Valproate-induced metabolic changes in patients with epilepsy: assessment with H-MRS. Epilepsia (2008) 0.85
Vocal tract and register changes analysed by real-time MRI in male professional singers-a pilot study. Logoped Phoniatr Vocol (2008) 0.85
The German Clinical Trials Register: challenges and chances of implementing a bilingual registry. J Evid Based Med (2009) 0.85
Transmission-associated nosocomial infections: prolongation of intensive care unit stay and risk factor analysis using multistate models. Am J Infect Control (2008) 0.84
Is pelvic lymphadenectomy really necessary in patients with a serum prostate-specific antigen level of <10 ng/ml undergoing radical prostatectomy for prostate cancer? BJU Int (2005) 0.84
Unusually quick resorption of an intracerebral hemorrhage in congenital afibrinogenemia. Neuroradiology (2002) 0.84
Letter to the editor. Biostatistics (2009) 0.83